ADHD medications do not increase risk of heart attack in children, young adults Attention Deficit Hyperactivity Disorder medications do not increase the risk for cardiovascular disease or heart attack in children and adults, according to a Vanderbilt study of 1 1.2 million patients taking medications including Ritalin, Adderall, Concerta and Strattera between 1998 and 2005. The study, published on-line today by the New England Journal of Medicine and authored by William Cooper, M colofac retard .D., MPH, a Vanderbilt Professor of Preventive and Pediatrics Medicine, may be the largest ever to examine potential risks posed by medicines to take care of ADHD. ‘It should be reassuring that people found no evidence these drugs increase the risk of serious cardiovascular events on a people basis,’ Cooper said.
The number of prescriptions for behavioural complications has risen by 156 percent within the last six years and in the last five years the National Health Service costs for stimulant drugs such as Ritalin offers trebled despite problems over the potential health risks. Research suggests that thousands of children are needlessly being prescribed mind-altering powerful medicines for hyperactivity with some GPs prescribing Ritalin to children under a year previous and in the last decade the number of school children recommended anti-depressants such as Prozac provides risen four instances. Related StoriesStudy links antibiotic use during childhood to fat gainCombatting viral and bacterial lung infections with volatile anesthetics: an interview with Dr ChakravarthyWhy do we rest? An interview with Professor WisdenThose diagnosed with ADHD often screen disruptive behaviour and have difficulty paying attention to specific tasks but official guidelines recommend medications limited to the most severely affected children.